Entrada Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-0.254; its P/E ratio is -56.43; Entrada Therapeutics Inc is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 41.85M	$ 43.73M	$ 18.17M	$ 25.26M	-
Gross Profit	$ 41.85M	$ 43.73M	$ 18.17M	$ 25.26M	-
EBIT	$ 3.21M	$ 36.13M	$ -12.08M	$ -6.25M	$ -24.63M
EBITDA	$ 1.92M	$ 35.07M	$ -12.97M	$ -5.98M	$ -24.23M
Net Income Common Stockholders	$ -15.53M	$ 53.53M	$ -25.93M	$ -9.85M	$ -24.63M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 67.60M	$ 51.88M	$ 79.74M	$ 227.65M	$ 45.16M
Total Assets	$ 469.19M	$ 485.03M	$ 493.98M	$ 475.57M	$ 252.06M
Total Debt	$ 68.23M	$ 69.07M	$ 73.03M	$ 16.23M	$ 25.94M
Net Debt	$ 628.00K	$ 17.19M	$ -6.71M	$ -211.42M	$ -19.22M
Total Liabilities	$ 226.83M	$ 238.37M	$ 287.07M	$ 245.96M	$ 39.50M
Stockholders Equity	$ 242.36M	$ 246.66M	$ 206.90M	$ 229.61M	$ 212.55M
Cash Flow	-
Free Cash Flow	$ -4.99M	$ -25.94M	$ -36.54M	$ 201.69M	$ -28.01M
Operating Cash Flow	$ -4.01M	$ -24.49M	$ -35.02M	$ 203.36M	$ -27.30M
Investing Cash Flow	$ 19.04M	$ -3.74M	$ -113.26M	$ -40.44M	$ 18.79M
Financing Cash Flow	$ 690.00K	$ 368.00K	$ 443.00K	$ 19.54M	$ 358.00K

Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History

Income Statement >

Entrada Therapeutics Inc Debt to Assets

Balance Sheet >

Entrada Therapeutics Inc Cash Flow

Cash Flow >

Entrada Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing